Mannatech (NASDAQ:MTEX) Earns Buy Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Mannatech (NASDAQ:MTEX) in a report issued on Tuesday. The firm issued a buy rating on the stock.

Mannatech Price Performance

Shares of NASDAQ MTEX opened at $7.86 on Tuesday. The stock has a market cap of $14.78 million, a P/E ratio of -9.70 and a beta of 1.17. The firm’s 50-day simple moving average is $7.85 and its 200 day simple moving average is $7.56. Mannatech has a fifty-two week low of $6.75 and a fifty-two week high of $10.51. The company has a quick ratio of 0.74, a current ratio of 1.25 and a debt-to-equity ratio of 0.44.

Mannatech (NASDAQ:MTEX) last released its quarterly earnings results on Tuesday, November 12th. The company reported ($0.17) EPS for the quarter. The company had revenue of $31.73 million for the quarter. Mannatech had a negative return on equity of 15.62% and a negative net margin of 1.26%.

Insider Activity

In other Mannatech news, Director Larry A. Jobe sold 16,288 shares of the company’s stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $7.75, for a total value of $126,232.00. Following the completion of the sale, the director now directly owns 54,721 shares of the company’s stock, valued at approximately $424,087.75. This represents a 22.94 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 41.50% of the stock is owned by insiders.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.